Skip to content

Ayurvedic Treatment for difficulty in breathing

Pharmaceutical standardization of vasaharitakyavaleha & granules and their effect on Tamaka shwasa (bronchial asthma).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023449
Enrollment
60
Registered
2020-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: vasaharitakyavaleha: 6gm of vasaharitakyavleha twice a day for 28 days Control Intervention1: vasaharitakyadigrannules: 6gm of vasaharitakyadigrannules twice a day for 28 days

Sponsors

Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs and symptoms of Tamaka swasa. Both the sexes having age between 18 years to 60 years. Mild persistent cases of Bronchial Asthma with daytime symptoms 3-6/week and nocturnal symptoms with 3-4/month. Moderate persistence cases with daytime symptoms daily and nocturnal symptoms with one or more than one week but not more than 2 weeks.

Exclusion criteria

Exclusion criteria: Age more than 60 years and below 18 years. Dyspnoea resulting from other diseases like left ventricular failure, upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc. Patients having anemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions. Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive will be excluded. HIV positive cases. Pregnant/lactating mother. Patients who need Salbutamol inhaler daily.

Design outcomes

Primary

MeasureTime frame
Improvement in classical sign and symptoms of Tamaka Swasa.Timepoint: 28 days

Secondary

MeasureTime frame
Change in ACQ quessionaireTimepoint: 18 Months

Countries

India

Contacts

Public ContactDr Neelam

All India Institute of Ayurveda

prajapati.pradeep1@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026